Search results
Results From The WOW.Com Content Network
Metoprolol is available as two different salts: metoprolol tartrate and metoprolol succinate. The main difference between metoprolol tartrate and metoprolol succinate is that metoprolol tartrate is only available as an immediate-release tablet which means it must be taken several times per day, whereas metoprolol succinate is an extended-release tablet that can be taken once a day.
Metoprolol is available as two different salts: metoprolol tartrate and metoprolol succinate. The main difference between metoprolol tartrate and metoprolol succinate is that metoprolol tartrate is only available as an immediate-release tablet which means it must be taken several times per day, whereas metoprolol succinate is an extended-release tablet that can be taken once a day.
4. Bottom Line. Metoprolol succinate ER is a selective beta-blocker that is used to lower blood pressure or relieve symptoms of angina in people with heart disease. It may also be used in the treatment of certain types of heart failure. Metoprolol succinate is not interchangeable with metoprolol tartrate.
Metoprolol succinate extended release tablets: 25 mg orally once a day (12.5 mg orally once a day in patients with more severe heart failure); double dose every 2 weeks to highest tolerated dose or up to 200 mg orally once a day. Usual Pediatric Dose for Hypertension: Metoprolol succinate extended release tablets: 6 Years or Older:
Lower once-daily doses may not maintain full effect at the end of the 24-hour period; larger or more frequent daily doses may be required. Beta-1 selectivity diminishes as the dose is increased. METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS: Initial dose: 25 to 100 mg orally once a day. Maintenance dose: 100 to 400 mg orally once a day.
blurred vision. chest pain or discomfort. confusion. dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position. slow or irregular heartbeat. sweating. unusual tiredness or weakness. Less common. bloating or swelling of the face, arms, hands, lower legs, or feet.
Metoprolol succinate extended-release tablets, metoprolol succinate, is a beta-adrenergic blocker indicated for the treatment of: •. Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) •.
Metoprolol succinate extended-release tablets, are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) Angina Pectoris. (1.2)
Metoprolol succinate. Metoprolol succinate lowers blood pressure and relieves symptoms of angina in people with heart disease. Slow-release forms of metoprolol succinate may be beneficial in people with certain types of heart failure. Available as a slow-release tablet which is usually dosed once a day.
Metoprolol is available as two different salts: metoprolol tartrate and metoprolol succinate. The main difference between metoprolol tartrate and metoprolol succinate is that metoprolol tartrate is only available as an immediate-release tablet which means it must be taken several times per day, whereas metoprolol succinate is an extended-release tablet that can be taken once a day.